Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Dishevelled Proteins of Wnt Signaling Pathways Are Highly Expressed in Chronic Lymphocytic Leukemia

Abdul Salam Khan, Åsa Sandin, Anders Österborg, MD, PhD, Mohammad Hojjat-Farsangi, Håkan Mellstedt, MD, PhD, Ali Moshfegh, PhD

Blood (2012) 120 (21): 4583.

https://doi.org/10.1182/blood.V120.21.4583.4583

Published: 2012

Journal Articles

Monoclonal Antibody Against ROR1 in Chronic Lymphocytic Leukemia Cells Induced Apoptosis Via PI3-Kinase/AKT/CREB Pathway

Amir Hossein Daneshmanesh, MD, PhD, Mohammad Hojjat-Farsangi, PhD, Asa Sandin, PhD, Abdul Salam Khan, Msc, Ali Moshfegh, PhD, Mahmood Jeddi-Tehrani, PhD, Anders Österborg, MD, PhD, Håkan Mellstedt, MD, PhD

Blood (2012) 120 (21): 1769.

https://doi.org/10.1182/blood.V120.21.1769.1769

Published: 2012

Journal Articles

Randomized Phase II Study of BLP25 Liposome Vaccine (L-BLP25) in Patients with Multiple Myeloma

Eva Rossmann, Anders Österborg, Eva Löfvenberg, Aniruddha Choudhury, Ulf Forssmann, Stefanie Senger, Andreas Schröder, Håkan Mellstedt

Blood (2011) 118 (21): 2927.

https://doi.org/10.1182/blood.V118.21.2927.2927

Published: 2011

Journal Articles

Patients with Chronic Lymphocyte Leukemia (CLL) Have Naturally Occurring Antibodies Against the Receptor Tyrosine Kinase (ROR1)

Mohammad Hojjat-Farsangi, PhD, Fariba Mozaffari, Ph.D, Amir Hossein Daneshmanesh, MD, Ph.D, Anders Osterborg, MD, PhD, Fazel Shokri, Ph.D, Håkan Mellstedt, MD, Ph.D

Blood (2011) 118 (21): 1771.

https://doi.org/10.1182/blood.V118.21.1771.1771

Published: 2011

Journal Articles

T Cells From CLL Patients Recognize Spontaneously Peptides Derived of the Receptor Tyrosine Kinase Ror1

Mohammad Hojjat -Farsangi, Ph.D, Amir Hossein Daneshmanesh, MD, Mahmood Jeddi-Tehrani, Ph.D, Anders Osterborg, MD, PhD, Fazel Shokri, Ph.D, Håkan Mellstedt, MD, Ph.D, Hodjattallah Rabbani, Ph.D

Blood (2010) 116 (21): 3603.

https://doi.org/10.1182/blood.V116.21.3603.3603

Published: 2010

Journal Articles

Small Leucine Rich Proteoglycans as Novel Tumor Markers In Chronic Lymphocytic Leukemia

Eva Mikaelsson, Mahmood Jeddi-Tehrani, Sr., Anders Ã–Sterborg, MD, PhD, Fazel Shokri, Hodjattallah Rabbani, Håkan Mellstedt

Blood (2010) 116 (21): 694.

https://doi.org/10.1182/blood.V116.21.694.694

Published: 2010

Journal Articles

Expression of Human Telomerase Reverse Transcriptase (hTERT) Splice Variants In Chronic Lymphocytic Leukemia (CLL)

Marzia Palma, MD, PhD, Parviz Kokhaei, PhD, Lotta Hansson, MD, PhD, Mohammad Hojat-Farsangi, PhD, Aniruddha Raja Choudhury, PhD, Anders Osterborg, MD, PhD, Håkan Mellstedt, MD, PhD

Blood (2010) 116 (21): 2413.

https://doi.org/10.1182/blood.V116.21.2413.2413

Published: 2010

Journal Articles

Immunological Responses in CLL Patients Vaccinated with Autologous Dendritic Cells Loaded with Apoptotic Bodies (Apo-DC).

Aniruddha Choudhury, MSc, PhD, Marzia Palma, M.D., Lotta Hansson, M.D., Ph.D., Karin Widen, Ingrid Eriksson, Barbro Nasman-Glaser, Lars Adamson, Anders Osterborg, M.D., Ph.D., Håkan Mellstedt, M.D., Ph.D.

Blood (2007) 110 (11): 2061.

https://doi.org/10.1182/blood.V110.11.2061.2061

Published: 2007

Journal Articles

Comparison of Gene Expression between T Cells from CLL Patients, Myeloma Patients and Healthy Individuals.

Aniruddha Choudhury, MSc, PhD, Anders Osterborg, M.D., Ph.D., Kaveh Mashayakhi, Ph.D., Ali Mosfegh, Ph.D., Shahryar Kiaii, Ph.D., Håkan Mellstedt, M.D., Ph.D.

Blood (2007) 110 (11): 4674.

https://doi.org/10.1182/blood.V110.11.4674.4674

Published: 2007

Journal Articles

Expression of Erythropoietin Receptor (EPO-R) and In Vitro Functional Effects of Epoetin in B-Cell Malignancies.

Amir Abdalla, Parviz Kokhaei, Lotta Hansson, Manfred Kubbies, Anton Haselbeck, Eva Mikaelsson, Helena Jernberg-Wiklund, Håkan Mellstedt, Anders Österborg Österborg

Blood (2005) 106 (11): 4278.

https://doi.org/10.1182/blood.V106.11.4278.4278

Published: 2005

Journal Articles

Reconstitution of the T Cell Repertoire Following Treatment with Alemtuzumab in Patients with B-Cell Chronic Lymphocytic Leukemia (B-CLL).

Mohammad R. Rezvany, Mahmood J. Tehrani, Claes Karlsson, Jeanette Lundin, Hodjattallah Rabbani, Håkan Mellstedt, Anders Österborg

Blood (2005) 106 (11): 2986.

https://doi.org/10.1182/blood.V106.11.2986.2986

Published: 2005

Journal Articles

Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma

Eva Mikaelsson, Amir Hossein Danesh-Manesh, Alfred Lüppert, Mahmood Jeddi-Tehrani, Mohammad-Reza Rezvany, Ramazan Ali Sharifian, Reza Safaie, Azam Roohi, Anders Österborg, Fazel Shokri, Håkan Mellstedt, Hodjattallah Rabbani

Blood (2005) 105 (12): 4828–4835.

https://doi.org/10.1182/blood-2004-10-3941

Published: 2005

Journal Articles

T-Cell Function in Patients with B-Cell Chronic Lymphocytic Leukemia (B-CLL) Following Alemtuzumab (Campath®) or Fludarabine Treatment.

Shahryar Kiaii, Fariba Mozaffari, Jeanette Lundin, Reza Rezvany, Aniruddha Chudhury, Håkan Mellstedt, Anders Osterborg

Blood (2004) 104 (11): 2513.

https://doi.org/10.1182/blood.V104.11.2513.2513

Published: 2004

Journal Articles

Downregulating the Fibromodulin Gene by Short Interfering RNA Causes B-CLL Cell Death.

Aniruddha Choudhury, Ph.D., Katja Derkow, B.S., Eva Mikaelsson, B.S., Parviz Kokhaei, B.S, Anders Österborg, M.D., Ph.D., Hodjattallah Rabbani, Ph.D., Håkan Mellstedt, M.D., Ph.D.

Blood (2004) 104 (11): 176.

https://doi.org/10.1182/blood.V104.11.176.176

Published: 2004

Journal Articles

Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration

Geoff Hale, Peppy Rebello, Lee R. Brettman, Chris Fegan, Ben Kennedy, Eva Kimby, Mike Leach, Jeanette Lundin, Håkan Mellstedt, Paul Moreton, Andy C. Rawstron, Herman Waldmann, Anders Osterborg, Peter Hillmen

Blood (2004) 104 (4): 948–955.

https://doi.org/10.1182/blood-2004-02-0593

Published: 2004

Journal Articles

T-cell epitopes within the complementarity-determining and framework regions of the tumor-derived immunoglobulin heavy chain in multiple myeloma

Lotta Hansson, Hodjattallah Rabbani, Jan Fagerberg, Anders Österborg, Håkan Mellstedt

Blood (2003) 101 (12): 4930–4936.

https://doi.org/10.1182/blood-2002-04-1250

Published: 2003

Journal Articles

Idiotype vaccination in multiple myeloma induced a reduction of circulating clonal tumor B cells

Thomas Rasmussen, Lotta Hansson, Anders Österborg, Hans Erik Johnsen, Håkan Mellstedt

Blood (2003) 101 (11): 4607–4610.

https://doi.org/10.1182/blood-2002-06-1925

Published: 2003

NARROW

Dishevelled Proteins of Wnt Signaling Pathways Are Highly Expressed in Chronic Lymphocytic Leukemia

Monoclonal Antibody Against ROR1 in Chronic Lymphocytic Leukemia Cells Induced Apoptosis Via PI3-Kinase/AKT/CREB Pathway

Randomized Phase II Study of BLP25 Liposome Vaccine (L-BLP25) in Patients with Multiple Myeloma

Patients with Chronic Lymphocyte Leukemia (CLL) Have Naturally Occurring Antibodies Against the Receptor Tyrosine Kinase (ROR1)

T Cells From CLL Patients Recognize Spontaneously Peptides Derived of the Receptor Tyrosine Kinase Ror1

Small Leucine Rich Proteoglycans as Novel Tumor Markers In Chronic Lymphocytic Leukemia

Expression of Human Telomerase Reverse Transcriptase (hTERT) Splice Variants In Chronic Lymphocytic Leukemia (CLL)

Immunological Responses in CLL Patients Vaccinated with Autologous Dendritic Cells Loaded with Apoptotic Bodies (Apo-DC).

Comparison of Gene Expression between T Cells from CLL Patients, Myeloma Patients and Healthy Individuals.

Expression of Erythropoietin Receptor (EPO-R) and In Vitro Functional Effects of Epoetin in B-Cell Malignancies.

Reconstitution of the T Cell Repertoire Following Treatment with Alemtuzumab in Patients with B-Cell Chronic Lymphocytic Leukemia (B-CLL).

Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma

T-Cell Function in Patients with B-Cell Chronic Lymphocytic Leukemia (B-CLL) Following Alemtuzumab (Campath®) or Fludarabine Treatment.

Downregulating the Fibromodulin Gene by Short Interfering RNA Causes B-CLL Cell Death.

Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration

T-cell epitopes within the complementarity-determining and framework regions of the tumor-derived immunoglobulin heavy chain in multiple myeloma

Idiotype vaccination in multiple myeloma induced a reduction of circulating clonal tumor B cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only